Cargando…
Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia, increases the morbidity and mortality of cardiovascular disease, type 2 diabetes, nonalcoholic fatty liver disease, and other metabolic diseases. It is well known that insulin resistance, especially hepatic insul...
Autores principales: | Su, Zuqing, Nie, Yutong, Huang, Xiufang, Zhu, Ying, Feng, Bing, Tang, Lipeng, Zheng, Guangjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795753/ https://www.ncbi.nlm.nih.gov/pubmed/31649547 http://dx.doi.org/10.3389/fphar.2019.01193 |
Ejemplares similares
-
Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders
por: Su, Zuqing, et al.
Publicado: (2021) -
Kun-Dan Decoction Ameliorates Insulin Resistance by Activating AMPK/mTOR-Mediated Autophagy in High-Fat Diet-Fed Rats
por: Su, Zuqing, et al.
Publicado: (2021) -
Punicalagin Alleviates Psoriasis by Inhibiting NF-κB-Mediated IL-1β Transcription and Caspase-1-Regulated IL-1β Secretion
por: Tang, Lipeng, et al.
Publicado: (2022) -
Mitophagy: A potential therapeutic target for insulin resistance
por: Ning, Peng, et al.
Publicado: (2022) -
Optineurin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration
por: Hu, Zhilei, et al.
Publicado: (2022)